Abivax Société Anonyme
(NASDAQ) ABVX
Abivax Société Anonyme Financials at a Glance
Market Cap
$7.91B
Revenue (TTM)
€0.00
Net Income (TTM)
-€427.24M
EPS (TTM)
-$5.25
P/E Ratio
-18.87
Dividend
$0.00
Beta (Volatility)
0.85 (Low)
Dividend
$0.00
Beta (Volatility)
0.85 (Low)
Price
$99.04
Volume
1,701,700.291
Open
$100.55
Price
$99.04
Volume
1,701,700.291
Open
$100.55
Previous Close
$99.15
Daily Range
$97.83 - $101.49
52-Week Range
$5.69 - $148.83
Estimated Earnings Date
Sep 14, 2026
Dividend
$0.00
Beta (Volatility)
0.85 (Low)
Price
$99.04
Volume
1,701,700.291
Open
$100.55
Previous Close
$99.15
Daily Range
$97.83 - $101.49
52-Week Range
$5.69 - $148.83
Estimated Earnings Date
Sep 14, 2026
ABVX News
ABVX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Abivax Société Anonyme
Industry
Biotechnology
Sector
Health CareEmployees
69
CEO
Marc M. P. de Garidel, EMBA
Website
www.abivax.comHeadquarters
Paris, 75008, FR
ABVX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-158%
Return on Capital
-48%
Return on Assets
-58%
Earnings Yield
-5.30%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$7.91B
Shares Outstanding
79.78M
Volume
1.70M
Avg. Volume
1.62M
Financials (TTM)
Gross Profit
€0.00
Operating Income
-€246.06M
EBITDA
-€300.70M
Operating Cash Flow
-€155.69M
Capital Expenditure
-€136.40K
Free Cash Flow
-€155.83M
Cash & ST Invst.
€530.16M
Total Debt
€32.08M
Abivax Société Anonyme Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
€0.00
-100.0%
Gross Profit
€0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
$7.91B
N/A
Market Cap/Employee
$114.64M
N/A
Employees
69
N/A
Net Income
-€287.69M
-200.3%
EBITDA
-€256.06M
-178.1%
Quarterly Fundamentals
Total Cash
€530.16M
+103.1%
Total Debt
€45.89M
-20.9%
Accounts Receivable
€10.49M
-45.1%
Inventory
€0.00
N/A
Long Term Debt
€16.49M
-38.4%
Short Term Debt
€29.40M
-6.0%
Return on Assets
-57.52%
N/A
Return on Invested Capital
-48.08%
N/A
Free Cash Flow
-€71.28M
+0.0%
Operating Cash Flow
-€71.28M
-0.2%